Impact of pulmonary disease on the prognosis in heart failure with preserved ejection fraction: the TOPCAT trial

Sergio H.R. Ramalho, Brian L. Claggett, Nancy K. Sweitzer, James C. Fang, Sanjiv J. Shah, Inder S. Anand, Bertram Pitt, Eldrin F. Lewis, Marc A. Pfeffer, Scott D. Solomon, Amil M. Shah

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)557-559
Number of pages3
JournalEuropean Journal of Heart Failure
Volume22
Issue number3
DOIs
StatePublished - Mar 1 2020

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Ramalho, S. H. R., Claggett, B. L., Sweitzer, N. K., Fang, J. C., Shah, S. J., Anand, I. S., Pitt, B., Lewis, E. F., Pfeffer, M. A., Solomon, S. D., & Shah, A. M. (2020). Impact of pulmonary disease on the prognosis in heart failure with preserved ejection fraction: the TOPCAT trial. European Journal of Heart Failure, 22(3), 557-559. https://doi.org/10.1002/ejhf.1593